Stockscreener 앱 받기
22.01
2.56%
0.55
전일 마감가:
$21.46
열려 있는:
$21.64
하루 거래량:
439.95K
Relative Volume:
0.65
시가총액:
$1.58B
수익:
$188.48M
순이익/손실:
$-143.14M
주가수익비율:
39.30
EPS:
0.56
순현금흐름:
$-158.83M
1주 성능:
+14.81%
1개월 성능:
+24.49%
6개월 성능:
+0.14%
1년 성능:
-29.39%
1일 변동 폭
$21.60
$22.19
1주일 범위
$18.84
$22.72
52주 변동 폭
$16.67
$38.00
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
SDGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
22.01 | 1.58B | 188.48M | -143.14M | -158.83M | 0.56 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Rubric Capital Management LP Grows Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Algert Global LLC Has $2.35 Million Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Massachusetts Financial Services Co. MA Purchases 717,059 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - MSN
Detailed Analysis of Molecular Modeling for Drug Development - openPR
Quest Partners LLC Purchases 39,218 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Schrödinger: Positive Signs Despite The Share Price Decline (SDGR) - Seeking Alpha
Gates Foundation awards second predictive toxicology grant - Philanthropy News Digest
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference - Business Wire
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN
Schrödinger, Novartis Ink Up-to-$2.3B Collaboration, Software Agreement - Genetic Engineering & Biotechnology News
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)November 19, 2024 - BioSpace
SDGRSchrodinger, Inc. Latest Stock News & Market Updates - StockTitan
Schrödinger, Inc. Receives an Additional $9.5 Million from the Bill & Melinda Gates Foundation - Marketscreener.com
Schrödinger Awards RSU Grants to New Employees Under Inducement Plan | SDGR Stock News - StockTitan
Biosimulation Market Dynamics and Future Opportunities | 2024 - openPR
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace
Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat
(SDGR) Technical Data - Stock Traders Daily
Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartz
Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com
Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business
Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com
Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com
Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com
Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online
Schrödinger announces collaboration with Novartis - The Pharma Letter
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript - Insider Monkey
Schrodinger announces expanded license agreement with Novartis - Yahoo Finance
Baillie Gifford & Co. Has $36.75 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher - Simply Wall St
Earnings call: Schrödinger reports dip in Q3 revenue, eyes Novartis deal - Investing.com UK
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
Schrödinger Reports Q3 2024 Earnings and New Novartis Collaboration - TipRanks
Schrödinger secures Novartis deal with potential $2.3 billion payout By Investing.com - Investing.com Australia
Schrödinger gains on Novartis deal despite Q3 miss - MSN
Blade Air Mobility Delivers Q3 Earnings Beat And Strong Margins As Restructuring Takes Flight - AOL
Schrodinger Inc (SDGR) Stock Price Up 13.36% on Nov 12 - GuruFocus.com
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Yahoo Finance
Schrödinger surges on Novartis collaboration agreement - ShareCast
Market news - Research the market
Schrödinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Schrödinger secures Novartis deal with potential $2.3 billion payout - Investing.com
Schrödinger enters collaboration pact with Novartis worth up to $2.5 billion - MarketWatch
Schrödinger Reports Third Quarter 2024 Financial Results - Business Wire
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
1.35%
자본화:
|
볼륨(24시간):